WO2025224508 - PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSIVE DISORDERS
National phase entry is expected:
Publication Number
WO/2025/224508
Publication Date
30.10.2025
International Application No.
PCT/IB2025/000189
International Filing Date
21.04.2025
Title **
[English]
PHARMACEUTICAL COMPOSITION FOR TREATING DEPRESSIVE DISORDERS
[French]
COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DE TROUBLES DÉPRESSIFS
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
KOIKE, Yusuke
SUGIYAMA, Yuichi
Priority Data
63/637,337
22.04.2024
US
63/640,771
30.04.2024
US
63/641,890
02.05.2024
US
63/641,908
02.05.2024
US
63/691,572
06.09.2024
US
63/707,311
15.10.2024
US
63/709,014
18.10.2024
US
63/767,686
06.03.2025
US
63/767,812
06.03.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 5175 | |
| EPO | Filing, Examination, Granting | 85586 | |
| Japan | Filing, Examination, Granting | 4652 | |
| South Korea | Filing, Examination, Granting | 7400 | |
| USA | Filing, Examination, Granting | 19940 |
Total:
122,753
Contact Us
Abstract[English]
Pharmaceutical compositions comprising (a) about 0.1 mg to about 5 mg 9-[4- (cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine2,2- dioxide ("COMPOUND A"); (b) a diluent; (c) a disintegrant; (d) a binder; and (e) a lubricant and methods of preparing the same are disclosed.[French]
L'invention concerne des compositions pharmaceutiques comprenant (a) environ 0,1 mg à environ 5 mg de 9-[4- (cyclohexyloxy)phényl]-7-méthyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine2,2- dioxide ("COMPOSÉ ") ; (b) un diluant ; (c) un délitant ; (d) un liant ; et (e) un lubrifiant et leurs procédés de préparation.